<DOC>
	<DOCNO>NCT00573651</DOCNO>
	<brief_summary>The purpose research study see patient juvenile idiopathic arthritis seronegative arthritis ( related condition ) mount protective immune response human papillomavirus ( HPV ) vaccine call Gardasil . The researcher also want monitor increase disease activity follow receipt vaccine .</brief_summary>
	<brief_title>Safety Efficacy Gardasil Females With Juvenile Idiopathic Arthritis ( JIA ) /Seronegative Arthritis</brief_title>
	<detailed_description>Each individual subject 's participation schedule last approximately two year . Patients give Gardasil injection month 0 , 2 , 6 . Patients geometric mean titer ( GMT ) measure 7 , 12 , 24 month . Questionnaires health function also complete visit .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Female patient , age 926 year , polyarticular JIA , pauciarticular JIA , seronegative arthritis . Pregnancy Known allergy/sensitivity hypersensitivity yeast component study drug formulation Systemic onset JIA active systemic symptom ( systemic onset JIA polyarticular feature fever rash may include ) . Prior vaccination HPV Known HPV infection Current history cervical cancer cervical intraepithelial neoplasia ( CIN ) . Males exclude study GardasilÂ® currently approve female .</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>JIA</keyword>
	<keyword>SEA syndrome</keyword>
	<keyword>AS</keyword>
	<keyword>psoriatic arthritis</keyword>
	<keyword>HPV vaccine</keyword>
</DOC>